Compare AIZ & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIZ | RDY |
|---|---|---|
| Founded | 1892 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.6B |
| IPO Year | N/A | N/A |
| Metric | AIZ | RDY |
|---|---|---|
| Price | $232.62 | $14.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $249.17 | $16.90 |
| AVG Volume (30 Days) | 284.0K | ★ 969.1K |
| Earning Date | 11-04-2025 | 01-22-2026 |
| Dividend Yield | ★ 1.54% | 0.51% |
| EPS Growth | ★ 17.21 | 9.95 |
| EPS | ★ 16.41 | 0.79 |
| Revenue | ★ $12,568,700,000.00 | $3,851,623,984.00 |
| Revenue This Year | $8.50 | $6.16 |
| Revenue Next Year | $5.73 | $2.57 |
| P/E Ratio | ★ $13.97 | $17.83 |
| Revenue Growth | 6.92 | ★ 14.10 |
| 52 Week Low | $174.97 | $12.26 |
| 52 Week High | $232.02 | $16.17 |
| Indicator | AIZ | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 53.57 |
| Support Level | $219.63 | $13.97 |
| Resistance Level | $226.59 | $14.16 |
| Average True Range (ATR) | 3.72 | 0.16 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 95.02 | 78.76 |
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.